Role of aspartic proteinases in candida albicans virulence. Part I. Substrate specificity of aspartic proteinases and candida albicans;Aspartylowej w wirulencji candida albicans czȩść I. Specyficzność substratowa proteazy aspartylowej a patogeneza zakażeń candida albicans

Postepy Mikrobiologii

Volumn 51, Issue 2, 2012, Pages 127-135

  Staniszewska, Monika ^a   Bondaryk, Małgorzata ^a   Siennicka, Katarzyna ^b   Piłat, Joanna ^c   Schaller, Martin ^d   Kurza̧tkowski, Wiesław ^a  

^a NATIONAL MEDICINES INSTITUTE   (Poland)

^b WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

^c WARSAW UNIVERSITY OF TECHNOLOGY   (Poland)

^d UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Aspartic proteinases; Candida albicans; Candidiasis; Virulence

Indexed keywords

ACID PHOSPHATASE; ASPARTIC PROTEINASE; BETA GLUCOSIDASE; BETA N ACETYLGALACTOSAMINIDASE; BETA N ACETYLHEXOSAMINIDASE; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C4B; GAMMA INTERFERON; LYMPHOTOXIN; LYSOPHOSPHOLIPASE; PHOSPHOLIPASE A; PHOSPHOLIPASE C; PHOSPHOLIPASE D; SECRETED ASPARTYL PROTEINASE 1; SECRETED ASPARTYL PROTEINASE 10; SECRETED ASPARTYL PROTEINASE 2; SECRETED ASPARTYL PROTEINASE 3; SECRETED ASPARTYL PROTEINASE 4; SECRETED ASPARTYL PROTEINASE 6; SECRETED ASPARTYL PROTEINASE 7; SECRETED ASPARTYL PROTEINASE 8; SECRETED ASPARTYL PROTEINASE 9; UNCLASSIFIED DRUG;

CANDIDA ALBICANS; CANDIDIASIS; CELL SURFACE; CYTOPLASM; ENZYME DEGRADATION; ENZYME SPECIFICITY; EPITHELIUM CELL; ESOPHAGUS CANDIDIASIS; FUNGAL STRAIN; FUNGAL VIRULENCE; FUNGUS HYPHAE; HUMAN; HYDROLYSIS; INNATE IMMUNITY; MUCOCUTANEOUS CANDIDIASIS; NONHUMAN; OROPHARYNX CANDIDIASIS; PATHOGENESIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SACCHAROMYCES CEREVISIAE; SKIN CANDIDIASIS; VAGINA CANDIDIASIS;

CANDIDA ALBICANS;

EID: 84864380035     PISSN: 00794252     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (100)

1. Abad-Zapatero C., Goldman R., Muchmore S. W., Hutchins C., Stewart K., Navaza J., Payne C.D., Ray T.: Structure of a secreted aspartic protease from C. albicans complexed with a potent inhibitor: implications for the design of antifungal agents. Protein Sci. 5, 640-65 (1996)
2. Abegg M.A., Lucietto R., Alabarse P.V.G., Mendes M.F.A., Benfato M.S.: Differential Resistance to Oxidants and Production of Hydrolytic Enzymes in Candida albicans. Mycopathologia, 171, 35-41 (2011)
3. Akçaǧlar S., Ener B., Töre O.: Acid proteinase enzyme activity in Candida albicans strains: a comparison of spectrophotometry and plate methods. Turk. J. Biol. 35, 559-567 (2011)
4. Albrecht A., Felk A., Pichova I., Naglik J.R., Schaller M., de Groot P., MacCallum D., Odds F.C., Schafer W., Klis F., Monod M., Hube B.: Glycosylphosphatidylinositol-anchored proteases of Candida albicans target proteins necessary for both cellular processes and host-pathogen interactions. J. Biol. Chem. 281, 688-694 (2006)
5. Barnett, J.A.: A history of research on yeasts 12: medical yeasts part I, Candida albicans. Yeast, 25, 385-417 (2008)
6. Bassetti M., Mikulska M., Viscoli C.: Bench-to-bedside review: Therapeutic management of invasive candidiasis in the intensive care unit. Crit. Care, 14, 244 doi:10.1186/cc9239 (2010)
7. Beauséjour A., Grenier D., Goulet J.P., Deslauriers N.: Proteolitic Activation of the Interleukin-1β Precursor by Candida albicans. Infect. Immun. 66, 676-681 (1998)
8. Bensadoun R.J., Patton L.L., Lalla R.V., Epstein J.B.: Oropharyngeal candidiasis in head neck cancer patients treated with radiation: update 2011. Support Care Cancer, 19, 737-744 (2011)
9. Bialková A., Šubík J.: Biology of the pathogenic yeast Candida glabrata. Folia Microbiol. 51, 3-20 (2006)
10. Białasiewicz D., Kurnatowska A.J.: Aktywność wybranych enzymów hydrolitycznych Candida albicans - szczepów wyizolowanych z ontocenozy jamy ustnej. Mikol. Lek. 3, 249-252 (1996)
11. +-inhibited germ tube formation of Candida albicans. ISHAM Med. Mycol. 38, 363-369 (2000)
12. Biswas S., Van Dijck P., Datta A.: Environmental Sensing and Signal Transduction Pathways Regulating Morphopathogenic Determinants of Candida albicans. Microbiol. Mol. Biol. Rev. 71, 348-376 (2007)
13. Borg M., Rüchel R.: Expression of extracellular acid proteinase by proteolytic Candida spp. during experimental infection of oral mucosa. Infect. Immun. 56, 626-631 (1988)
14. Borges-Walmsley M., Walmsley A.R.: cAMP signaling in pathogenic fungi: control of dimorphic switching and pathogenicity. Trends. Microbiol. 8, 133-141 (2000)
15. Borman A.M., Linton Ch. J., Miles S.J., Johnson E.M.: Molecular identification of pathogenic fungi. J. Antimicrob. Chemother. 61, i7-i12 (2008)
16. Borst A., Theelen B., Reinders E., Boekhout T., Fluit A.C., Savelkoul P.H.M.: Use of amplified fragment length polymorphism analysis to identify medically important Candida spp., including C. dublininsis. J. Clin. Microbiol. 41, 1357-1362 (2003).
17. Bouchara J.P., Tronchin G., Annaix V., Robert R., Senet J-M.: Laminin receptors on Candida albicans germ tube. Infect. Immun. 58, 48-54 (1990)
18. Brassart D., Woltz A., Golliard M., Neeser J-R.: In vitro inhibition of adhesion of Candida albicans clinical isolates to human buccal epithelial cells by Fuca1→2Galß-bearing complex carbohydrates. Innfect. Immun. 59, 1605-1613 (1991)
19. Brawner D.L., Smith F.O., Mori M., Nonoyama S.: Adherence of Candida albicans to tissue from mice with genetic immunodeficience. Infect. Immun. 59, 3069-3078 (1991)
20. Brown A.J.P.: Expression of growth form-specific factor during morphogenesis in Candida albicans. In: Calderone R.A. (ed) Candida and candidiasis. Washington: ASM Press. 2002, pp. 87-93
21. Brown A.J.P., Gow N.A.R.: Regulatory networks controlling Candida albicans morphogenesis. Trends. Microbiol. 7, 333-338 (1999)
22. Bruno V.M., Mitchell A.P.: Large-scale gene function analysis in Candida albicans. Trends. Microbiol. 12, 157-161 (2004)
23. Bulik C.C., Sobel J.D., Nailor M.D.: Susceptibility profile of vaginal isolates of Candida albicans prior to and following fluconazole introduction - impact of two decades. Mycoses, 1, 1-5 (2009)
24. Byoung-Kuk N., Gyung-Tae Ch., Chul-Young S.: Production, characterization, and epitope mapping of a monoclonal antibody against aspartic proteinase of Candida albicans. Clin. Diagn. Lab. Immunol. 6, 429-433 (1999)
25. Cagnacci S., Grasso R., Marchese A., Corvò R., Debbia E., Rossi L.: The susceptibility of Candida albicans to gamma-radiations and ketoconazole depends on transitional filamentation. Open. Microbiol. J. 2, 66-73 (2008)
26. Calderone R.A.: Taxonomy and Biology of Candida. In Calderone, R.A. (ed) Candida and candidiasis. Washington: ASM Press. 2002a, pp. 15-27.
27. Calderone R.A., Fonzi W. A.: Virulence factors of Candida albicans. Trends. Microbiol. 9, 327-334 (2001)
28. Calderone R.A., Gow N.A.R.: Host recognition by Candida species. In: Calderone R.A. (ed) Candida and candidiasis. Washington: ASM Press. 2002, pp. 67-86.
29. Cannom R.R., French S.W., Johnston D., Edwards Jr. J.E., Filler S.G.: Candida albicans stimulates local expression of leukocyte adhesion molecules and cytokines in vivo. J. Infect. Dis. 186, 389-396 (2002)
30. Carvalho A.P., Gursky L.C., Rosa R.T., Rymovicz A.U.M., Campelo P.M.S., Grégio A.M.T., Koga-Ito C.Y., Samaranayake L.P., Rosa E.A.R.: Non-steroidal anti-inflammatory drugs may modulate the protease activity of Candida albicans. Microb. Pathog. 49, 315-322 (2010)
31. • agar plate with germ-tube for presumptive identification of Candida albicans. Diagn. Micr. Infec. Dis. 42, 181-185 (2002)
32. Cárdenes C.D., Carrillo-Muñoz A.J., Arias A., Rodríguez-Alvarez C., Torres-Lana A., Sierra A., Areválo M.P.: Comparative evaluation of four commercial tests for presumptive identification of Candida albicans. J. Microbiol. Meth. 59, 293-297 (2004)
33. Cervera A.M., Gozalbo D, McCreath K.J., Gow N.A.R., Martinez J.P., Casanova M.: Molecular cloning and characterization of a Candida albicans gene coding for cytochrome c haem lyase and a cell wall-related protein. Mol. Microbiol. 30, 67-81 (2002)
34. Chauhan N., Li D., Singh P., Calderone R., Kruppa M.: The cell wall of Candida spp. In: Calderone R.A. (ed) Candida and candidiasis. Washington: ASM Press. 2002, pp. 159-175.
35. Chen Y. C., Wu C.C., Chung W.L., Lee F.J.S.: Differential secretion of Sap4-6 proteins in Candida albicans during hyphae formation. Microbiol. 148, 3743-3754 (2002)
36. Cho T., Aoyama T., Toyoda M., Nakayama H., Chibana H., Kaminishi H.: Transcriptional changes in Candida albicans genes by both farnesol and high cell density at an early stages of morphogenesis in N-acetyl-D-glucosamine medium. Jpn. J. Med. Mycol. 48, 159-167 (2007)
37. Conti H.R., Gaffen S.L.: Host responses to Candida albicans: Th17 cells mucosal candidiasis. Microb. Infect. 12, 518-527 (2010)
38. Copping V.M.S., Bareile C.J., Hube B., Gow N.A.R., Brown A.J.P., Odds F.: Exposure of Candida albicans to antifungal agents affects expression of SAP2 and SAP9 secreted proteinase genes. J. Antimicrob. Chemother. 55, 645-654 (2005)
39. Cullen P.J. and Sprague G.F.: Glucose depletion causes haploid invasive growth in yeast. Proc. Natl. Acard. Sci. USA, 97, 13619-13624 (2000)
40. Dalle F., Wächtler B., L'Ollivier C., Holland C., Bannert N., Wilson D., Labruère C., Bonnin A., Hube B.: Cellular interactions of Candida albicans with human epithelial cells and enterocytes. Cell. Microbiol. 12, 248-271 (2010)
41. De Bernardis F., Adriani D., Lorenzini R., Pontieri E., Carruba G., Cassone A.: Filamentous growth and elevated vaginopathy potential of a nongerminative variant of Candida albicans expressing low virulence in systemic infection. Infect. Immun. 61, 1500-1508 (1993)
42. De Bernardis F., Boccanera M., Adriani D., Spreghini E., Santoni G., Cassone A.: Protective role of antimannan and antiaspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats. Infect. Immun. 65, 3399-3405 (1997)
43. dos Santos A.L.S.: HIV aspartyl proteinase inhibitors as promising compounds against Candida albicans. World. J. Biol. Chem. 1, 21-30 (2010)
44. Dwivedi P., Thompson A., Xie Z., Kashleva H., Ganguly S., Mitchell A., Dongari-Bagtzoglou A.: Role of Bcr1-Activated Genes Hwp1 and Hyr1 in Candida Albicans Oral Mucosal Biofilms and Neutrophil Evasion. PLoS ONE, 6, e16218 (2011)
45. Eggimann P., Bille J., Marchetti O.: Diagnosis of invasive candidiasis in the ICU. Ann. Intensive Care, 1, 37 doi:10.1186/2110-5820-1-37 (2011)
46. Ehrström S., Daroczy K., Rylander E., Samuelsson C., Johannesson U., Anzén B., Påhlson C.: Lactic acid bacteria colonization and clinical outcome after probiotic supplementation in conventionally treated bacterial vaginosis and vulvovaginal candidiasis. Microb. Infect. 12, 691-699 (2010)
47. Enoch D.A., Ludlam H.A., Brown N.: Invasive fungal infections: a review of epidemiology and management options. J. Med. Microbiol. 55, 809-818 (2006)
48. Fekete A., Ermi T., Gyetvai A., Gazdag Z., Pesti M., Varga Z., Balla J., Cserháti C., Emödy L., Gergely L., Pócsi I.: Development of oxidative stress tolerance resulted in reduced ability to undergo morphologic transitions and decreased pathogoenicity in a t-butylhydroperoxide-tolerant mutant of Candida albicans. FEMS Yeast. Res. 7, 834-847 (2007)
49. Ferwerda G., Netea M.G., Joosten L.A., van der Meer J.W.M., Romain L., Kuliberg B.J.: The role of Toll-like receptors and C-type lectins for vaccination against Candida albicans. Vaccine, 28, 614-622
50. Gaffen S.L., Hernández-Santos N., Peterson A.C.: IL-17 signaling in host defense against Candida albicans. Immunol. Res. 50, 181-187 (2011)
51. Gácser A., Stehr F., Kröger K., Kredics L., Schäfer W., Nosanchuck J.D.: Lipase 8 Affects the Pathogenesis of Candida albicans. Infect. Immun. 75, 4710-4718 (2007)
52. Giraldo E., Martin-Cordero L., Hinchado M.D., Garcia J.J., Ortega E.: Role of phosphatidylinositol-3-kinase (PI3K), extracellular signal-regulated kinase (ERK) and nuclear transcription factor kappa β (NF-kβ) on neutrophil phagocytic process of Candida albicans. Mol. Cell. Biochem. 333, 115-120 (2010)
53. Gropp K., Schild L., Schindler S., Hube B., Zipfel RE, Skerka C.: The yeast Candida albicans evades human complement attack by secretion of aspartic proteases. Mol. Immun. 47, 465-475 (2009)
54. Haynes K.: Virulence in Candida species. Trends. Microbiol. 9, 591-596 (2001)
55. Hornbach A., Heyken A., Schild L., Hube B., Löffler J., Kurzai O.: The Glycosylphosphatidylinositol-Anchored Protease Sap9 Modulates the Interaction of Candida albicans with Human Neutrophils. Infect. Immun. 77, 5216-5224 (2009)
56. Hube B., Hess D., Baker C.A., Schaller M., Schäfer, Dolan J.W. The role and relevance of phospholipase D1 during growth and dimorphism of Candida albicans. Microbiol. 147, 879-889 (2001)
57. Hube B., Naglik J.: Candida albicans proteinases: resolving the mystery of the gene family. Microbiol. 147, 1997-2005 (2001)
58. Hube B., Naglik J.: Extracellular hydrolases. In: Calderone R.A. (ed) Candida and candidiasis. Washington: ASM Press. 2002, pp. 107-122.
59. Jacobsen M.D., Boekhout T., Odds F.C.: Multilocus sequence typing confirms synonymy but highlights differences between Candida albicans and Candida stellatoidea. FEMS Yeast. Res. 8, 764-770 (2008)
60. Kanbe T., Kurimoto K., Hattori H., Iwata T., Kikuchi A.: Rapid identification of Candida albicans and its related species Candida stellatoidea and Candida dubliniensis by a single PCR amplification Rusing primers specific for the repetitive sequence (RPS) of Candida albicans. J. Dermatol. Sci. 40, 43-50 (2005)
61. Kantarcioǧlu A.S., Yücel A.: Phospholipase and protease activities in clinical Candida isolates with reference to the sources of strains. Mycoses, 45, 160-165 (2002)
62. Kitanovic A, Nguyen M., Vogl G., Hartmann A., Günther J., Würzner R., Künkel W., Wölfl S., Eck R.: Phosphatidylinositol 3-kinase VPS34 of Candida albicans is involved in filamentous growth, secretion of aspartic proteases, and intracellular detoxification. FEMS Yeast Res. 5, 431-439 (2005)
63. Korting H.C., Patzak U., Schaller M., Maibach H.I.: A model of human cutaneous candidosis based on reconstructed human epidermis for the light and electron microscopic study of pathogenesis and treatment. J. Inf. Sci. 36, 259-267 (1998)
64. Korting H.C., Hube B., Oberbauer S., Januschke E., Hamm G., Albrecht A., Borelli C., Schaller M.: Reduced expression of the hyphal-independent Candida albicans proteinase genes SAP1 and SAP3 in the efg1 mutant is associated with attenuated virulence during infection of oral epithelium. J. Med. Microbiol. 52, 623-632 (2003)
65. Kullberg B.J., Filler S.G.: Candidemia. In: Calderone R.A. (ed) Candida and candidiasis. Washington: ASM Press. 2002, pp. 327-340
66. Lee S.A., Jones J., Hardison S., Kot J., Khalique Z., Bernardo S.M., Lazzell A., Monteagudo C., Lopez-Ribot J.: Candida albicans VPS4 is Required for Secretion of Aspartyl Proteases and In Vivo Virulence. Mycopathologia, 167, 55-63 (2009)
67. Lermann U, Morschhäuser J.: Secreted aspartic proteases are not required for invasion of reconstituted human epithelia by Candida albicans. Microbiol. 154, 3281-3295 (2008)
68. + T cells specific for Candida albicans are present in humans. Eur. J. Immunol. 39, 1472-1479 (2009)
69. López-Ribot J.L., Casanova M., Monteagudo C., Sepúlveda P., Martinez J.P.: Evidence for the presence of high-affinity laminin receptor-like molecule on the surface of Candida albicans yeast cells. Infect. Immune. 62, 742-746 (2004)
70. Mardegan R.C., Foglio M.A., Gonçalves R.B., Höfling J.F.: Candida albicans proteinases. Braz. J. Oral. Sci. 5, 944-952 (2006)
71. Miranda L.N., van der Heiden I.M., Costa S.R, Sousa A.P.I., Sienra R.A., Gobara S., Santos C.R., Lobo R.D., Pessoa Jr. V.P.: Candida colonisation as a souce for candidaemia. J. Hosp. Infect. 72, 9-16 (2009)
72. Monod M., Borg-von Zepelin M.: Secreted Aspartic proteases as virulence factors of Candida species. Biol. Chem. 383, 1087-1093 (2002)
73. Morrison C.J., Hurst S.F., Reiss E.: Competitive binding enzyme-linked immunosorbent assay that uses the secreted aspartyl proteinase of Candida albicans as an antigenic marker for diagnosis of disseminated candidiasis. Clin. Diagn. Lab. Immunol. 10, 835-848 (2003)
74. Naglik J.R., Newport G., White T.C., Fernandes-Naglik L., Greenspan J.S., Greenspan D., Sweet S.P., Challacombe S.J., Agabian N.: In vivo analysis of secreted aspartyl proteinase expression in human oral candidiasis. Infect. Immun. 67, 2482-2490 (1999)
75. Naglik J.R., Challacombe S.J., Hube B.: Candida albicans secreted aspartyl proteases in virulence and pathogenesis. Microbiol. Mol. Biol. Rev. 67, 400-428 (2003)
76. Naglik J., Albrecht A., Bader O., Hube B.: Candida albicans proteinases and host/pathogen interactions. Cell. Microbiol. 6, 915-926 (2004)
77. Naglik J.R., Moyes D., Makwana J., Kanzaria P., Tsichlaki E., Weindl G., Tappuni A.R., Rodgers C.A., Woodman A.J., Challacombe S.J., Schaller M., Hube B.: Quantitative expression of the Candida albicans secreted aspartyl proteinase gene family in human oral and vaginal candidiasis. Microbiol. 154, 3266-3280 (2008)
78. Nantel A., Dignard D., Bachewich C., Harcus D., Marcil A., Bouin A-P., Sensen Ch. W., Hogues H., van het Hoog M., Gordon P., Rigby T., Benoit F., Tessier D.C., Thomas D.Y., Whiteway M.: Transcription profiling of Candida albicans cells undergoing the yeast-to-hyphal transition. Mol. Biol. Cell. 13, 3452-3456 (2002)
79. Nguyen K.A., Zmeter G., Claris O., Kassai B.: Epidemiology of invasive Candida infection in a neonatal intensive care unit in France. Acta Paediatr. doi: 10.1111/j.1651-2227.2011.02514.x (2011)
80. Niimi K., Shepeherd M.G., Cannon R.D.: Distingusihing Candida species by β-N-acetylhexosaminidase activity. J. Clin. Microbiol. 39, 2089-2097 (2001)
81. Pichová I., Pavličkowa L., Dostál J., Dolejši E., Hrušková-Hidingsfeldowá O., Weber J., Ruml T., Souček M.: Secreted aspartic proteases of Candida albican, Candida tropicalis, Candida parapsilosis and Candida lusitaniae. FEBS Eur. J. Biochem. 268, 2669-2677 (2001)
82. Raška M., Běláková J., Křupka M., Weigl E.: Candidiasis - do we need to fight or to tolerate the Candida fungus? Folia Microbiol. 52, 297-312 (2007)
83. Rehaume L.M., Jouault T., Chamaillard M.: Lessons from the inflammasome: a molecular sentry linking Candida and Crohn's disease. Trends. Immunol. 31, 171-175 (2010)
84. Sampaio P., Santos M., Correia A., Amaral F.E., Chavéz-Galarza J., Costa-de-Oliveira S., Castro A.G., Pedrosa J., Pais C.: Virulence Attenuation of Candida albicans Genetic Variants Isolated from a Patient with a Recurrent Bloodstream Infection. PLoS ONE 5, e10155, doi:10.1371/journal.pone.0010155 (2010)
85. Schaller M., Schäfer W., Korting H.C., Hube B.: Differential expression of secreted aspartyl proteinases in a model of human oral candidiosis and in patient samples from oral cavity. Mol. Microbiol. 29, 605-615 (1998)
86. Schaller M., Korting H.C., Schäfer W., Bastert J., Chen W.C., Hube B.: Secreted aspartic proteinase (Sap) activity contributes to tissue damage in a model of human oral candidosis. Mol. Microbiol. 34, 169-180 (1999a)
87. Schaller M., Hube B., Ollert M.W., Schäfer W., Borg-von Zepelin M, Thoma-Greber M., Korting H.C.: In vivo expression and localization of Candida albicans secreted aspartyl proteinases during oral candidiasis in HIV- infected patients. J. Invest. Dermatol. 112, 383-389 (1999b)
88. Schaller M., Schackert C., Korting H.C., Janusche E., Hube B.: Invasion of Candida albicans correlates with expression of secreted aspartic proteinases during experimental infection of human epidermis. J. Invest. Dermatol. 114, 712-717 (2000)
89. Schaller M., Januschke E., Schackert C., Woerle B., Korting H.C.: Different isoforms of secreted aspartyl proteinases (Sap) are expressed by Candida albicans during oral and cutaneous candidiosis in vivo. J. Med. Microbiol. 50, 743-747 (2001)
90. Schaller M., Mailhammer R., Grassl G., Sander Ch. A., Hube B., Korting H.C.: Infection of human oral epithelia with Candida species induces cytokine expression correlated to the degree of virulence. J. Invest. Dermatol. 118, 652-657 (2002)
91. Schaller M., Bein M., Korting H.C., Baur S., Hamm G., Mond M., Beinhauer S., Hube B.: The secreted aspartyl proteinases Sap1 and Sap2 cause tissue damage in an in vitro model of vaginal cadidiasis based on reconstructed human vaginal epithelium. Infect. Immun. 71, 3227-3234 (2003)
92. Schaller M., Korting H.C., Borelli C., Hamm G., Hube B.: Candida albicans-Secreted Aspartic Proteinases Modify the Epithelial Cytokine Response in an In Vitro Model of Vaginal Candidiasis. Infect. Immun. 73, 2758-2765 (2005)
93. Schelenz S.: Management of candidiasis in the intensive care unit. J. Antimicrob. Chemother. 61, i31-i34 (2008)
94. Schild L., Heyken A., de Groot P.W.J., Hiller E., Mock M., de Koster C., Horn U., Rupp S., Hube B.: Proteolytic Cleavage of Covalently Linked Cell Wall Proteins by Candida albicans Sap9 and Sap10. Eucaryot Cell, 10, 98-109 (2011)
95. Schofield D.A., Westwater C., Warner T., Nicholas R.J., Paulling E.E., Balish E.: Hydrolytic gene expression during oroesophageal and gastric candidiasis in immunocompetent and immunodeficient gnotobiotic mice. J. Infect. Dis. 188, 591-599 (2003)
96. Silva S., Negri M., Henriques M., Oliveira R., Williams D., Azeredo J.: Silicone colonization by non-Candida albicans Candida species in the presence of urine. J. Med. Mycol. 59, 747-752 (2010)
97. Stringaro A., Crateri P., Pellegrini G., Arancia G., Cassone A., De Bernardis F.: Ultrastructural localization of the secretory aspartl proteinase in Candida albicans cell wall in vitro and in experimentally infected rat vagina. Mycopathologia, 137, 95-105 (1997)
98. Tavanti A., Pardini G., Campa D., Davini P., Lupetti A., Sonesi S.: Differential Expression of Secretory Aspartyl Proteinase Genes (SAP1-10) in Oral Candida albicans Isolates with Distinct Karyotypes. J. Clin. Microbiol. 42, 4726-4734 (2004)
99. Tongchusak S., Brusic V., Chaiyaroj S.C.: Promiscuous T cell epitope prediction of Candida albicans secretory aspartyl proteinase family of proteins. Infect. Genetics Evolution, 8, 467-473 (2008)
100. Zaoutis T.: Candidemia in children. Curr. Med. Res. Opin. 26, 1761-1768 (2010)